2018 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2016 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2023 | 0 | 6.771.571 | 0 | 1 | ||
2018 | 0 | 4.075.132 | 303.173 | 1 | ||
2017 | 0 | 3.933.617 | 273.288 | 1 | ||
2016 | 0 | 1.552.846 | 546.576 | 1 |
Total number of partners: 35
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 35
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2023-01-01 | GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION | GlycanTrigger | participant | 6.771.571 | 9 |
2018-10-01 | Glyco-Nanoparticles for Applications in Advance Nanomedicine | NanoCarb | participant | 4.075.132 | 16 |
2017-10-01 | Analytics for Biologics | A4B | participant | 3.933.617 | 11 |
2016-10-01 | Exploitation of Glycosylation Signatures for Precision Medicine | GlySign | participant | 1.552.846 | 3 |